Stay updated on LAG525 and Spartalizumab Combination in Advanced TNBC Clinical Trial
Sign up to get notified when there's something new on the LAG525 and Spartalizumab Combination in Advanced TNBC Clinical Trial page.

Latest updates to the LAG525 and Spartalizumab Combination in Advanced TNBC Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedA new revision entry v3.6.5 appears in the study history, replacing the previous v3.6.4. This indicates the record was updated to a new version after QC, without substantive changes to the study information.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe record history now shows a new revision entry (v3.6.4). The prior revision (v3.6.3) is removed from the list.SummaryDifference0.0%

- Check55 days agoChange DetectedThe study history now includes a new revision entry v3.6.3. The previous revision v3.6.0 has been removed.SummaryDifference0.0%

- Check70 days agoChange DetectedThe history shows the study is no longer recruiting participants and updates the record to revision v3.6.0, replacing v3.5.5.SummaryDifference0.2%

- Check77 days agoChange DetectedThe study record history now includes a new revision entry (v3.5.5), and the previous revision entry (v3.5.4) is removed from the history.SummaryDifference0.1%

- Check98 days agoChange DetectedRevision: v3.5.4 replaces the previous Revision: v3.5.3, indicating a new release of the page. This change reflects behind-the-scenes updates to the page rather than changes to the trial information.SummaryDifference0.1%

Stay in the know with updates to LAG525 and Spartalizumab Combination in Advanced TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LAG525 and Spartalizumab Combination in Advanced TNBC Clinical Trial page.